Coherence of the Knowledge Base and the Firm's Innovative Performance: Evidence from the U.S. Pharmaceutical Industry

We examine the relationship between the coherence of the knowledge base and the innovative performance of U.S. pharmaceutical firms during the 1990's. We develop measures of the coherence and scope of the firms' knowledge base. Count data regression models show a strong link between these two properties and the firms' innovative performance. Firms experience decreasing returns to scale in research but larger firms enjoy a significant size advantage in innovation. Knowledge flows are necessary in knowledge production but not sufficient to secure its quality. Over time, the contribution of the scope and coherence of the knowledge base is increasing.

[1]  Luigi Orsenigo,et al.  The emergence of biotechnology , 1989 .

[2]  D Schwartzman.  "Innovation in the Pharmaceutical Industry". , 1978, British medical journal.

[3]  I. Cockburn,et al.  Measuring competence?: exploring firm effects in pharmaceutical research , 1994 .

[4]  J. Schumpeter,et al.  The Theory of Economic Development , 2017 .

[5]  J J Fitzpatrick,et al.  Little science. , 1991, Applied nursing research : ANR.

[6]  A. Arora,et al.  Evaluating technological information and utilizing it: Scientific knowledge, technological capability, and external linkages in biotechnology , 1994 .

[7]  K Palepu.  多角化戦略,収益性業績,エントロピー測度 , 1985 .

[8]  Cynthia A. Montgomery,et al.  The Measurement of Firm Diversification: Some New Empirical Evidence , 1982 .

[9]  B. Spilker,et al.  Science and Innovation: The US Pharmaceutical Industry During the 1980s , 1996 .

[10]  A. Arora,et al.  The changing technology of technological change: general and abstract knowledge and the division of , 1994 .

[11]  Samuel B. Graves,et al.  Innovative productivity and returns to scale in the pharmaceutical industry , 1993 .

[12]  Andreas Pyka,et al.  Innovation Networks in the Biotechnology-Based Sectors , 2001 .

[13]  Z. Griliches,et al.  Econometric Models for Count Data with an Application to the Patents-R&D Relationship , 1984 .

[14]  John T. Scott,et al.  Purposive Diversification of R and D in Manufacturing , 1987 .

[15]  K. Palepu.  Diversification strategy, profit performance and the entropy measure , 1985 .

[16]  William S. Comanor,et al.  Research and Technical Change in the Pharmaceutical Industry , 1965 .

[17]  John T. Scott.  Purposive Diversification and Economic Performance , 1993 .

[18]  I. Cockburn,et al.  Scale, scope, and spillovers: the determinants of research productivity in drug discovery. , 1996, The Rand journal of economics.

[19]  Henry G. Grabowski,et al.  Innovation and Structural Change in Pharmaceuticals and Biotechnology , 1994 .

[20]  Cynthia A. Montgomery,et al.  Diversified expansion by large established firms , 1991 .

[21]  Vasudevan Ramanujam,et al.  Research on corporate diversification: A synthesis , 1989 .

[22]  M. Trajtenberg.  A Penny for Your Quotes : Patent Citations and the Value of Innovations , 1990 .

[23]  A. Jaffe.  Technological Opportunity and Spillovers of R&D: Evidence from Firms&Apos; Patents, Profits and Market Value , 1986 .

[24]  I. Cockburn,et al.  Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery , 2003 .

[25]  Zvi Griliches,et al.  Issues in Assessing the Contribution of Research and Development to Productivity Growth , 1979 .

[26]  J. R. Moore,et al.  The theory of the growth of the firm twenty-five years after , 1960 .

[27]  F. Scherer,et al.  Using Linked Patent and R&D Data to Measure Interindustry Technology Flows , 1984 .

[28]  Edwin Mansfield,et al.  Basic Research and Productivity Increase in Manufacturing , 1980 .

[29]  Elizabeth J. Jensen.  Research Expenditures and the Discovery of New Drugs , 1987 .

[30]  A. Arora,et al.  COMPLEMENTARITY AND EXTERNAL LINKAGES: THE STRATEGIES OF THE LARGE FIRMS IN BIOTECHNOLOGY* , 1990 .

[31]  D. Leonard-Barton.  CORE CAPABILITIES AND CORE RIGIDITIES: A PARADOX IN MANAGING NEW PRODUCT DEVELOPMENT , 1992 .

[32]  Diane Lambert,et al.  Zero-inflacted Poisson regression, with an application to defects in manufacturing , 1992 .

[33]  Max Boisot,et al.  Is your firm a creative destroyer? Competitive learning and knowledge flows in the technological strategies of firms , 1995 .

[34]  A. Gambardella.  Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s * , 1992 .

[35]  Paul Nightingale,et al.  Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D , 2000 .

[36]  John M. Vernon,et al.  Technical Change and Firm Size: The Pharmaceutical Industry , 1974 .

[37]  Keith Pavitt,et al.  USES AND ABUSES OF PATENT STATISTICS , 1988 .

[38]  Francis Narin,et al.  Citation rates to technologically important patents , 1981 .

[39]  A. Cameron,et al.  Econometric models based on count data. Comparisons and applications of some estimators and tests , 1986 .

[40]  S. Hart.  New Product Development , 1995 .

[41]  D. Teece,et al.  The Dynamic Capabilities of Firms: an Introduction , 1994 .

[42]  Stephen Hill,et al.  The theory of the growth of the firm , 1981 .

[43]  Manuel Trajtenberg,et al.  THE NBER/SLOAN PROJECT ON INDUSTRIAL TECHAIOLOGY AND PRODUCTIVITY: INCORPORATING LEARNING FROM PLANT VISITS AND INTERVIEWS INTO ECONOMIC RESEARCHt Knowledge Spillovers and Patent Citations: Evidence from a Survey of Inventors , 2000 .

[44]  Cynthia A. Montgomery,et al.  Diversification, market structure, and firm performance : an extension of Rumelt's model , 1979 .

[45]  Daniele Archibugi,et al.  Patenting as an indicator of technological innovation: a review , 1992 .

[46]  F. Malerba,et al.  Knowledge-relatedness in firm technological diversification , 2003 .

[47]  S. Winter,et al.  An evolutionary theory of economic change , 1983 .

[48]  R. Rumelt.  Strategy, structure, and economic performance , 1974 .

[49]  Manuel Trajtenberg,et al.  Market Value and Patent Citations: A First Look , 2000 .

[50]  Francis Narin,et al.  Technological performance assessments based on patents and patent citations , 1984, IEEE Transactions on Engineering Management.

[51]  Maureen McKelvey.  Evolutionary Innovations: The Business of Biotechnology , 1996 .

[52]  P. McCullagh,et al.  Generalized Linear Models , 1984 .

[53]  Zvi Griliches,et al.  Productivity, R&D, and Basic Research at the Firm Level in the 1970s , 1985 .

[54]  S. Winter,et al.  Understanding corporate coherence: Theory and evidence , 1994 .